Use access key #2 to skip to page content.

IBDvalueinvestin (99.66)

Generic drug company of Woodcliff,NJ is down -0.87 after blowing away estimates

Recs

2

November 06, 2009 – Comments (1) | RELATED TICKERS: PRX.DL2

Sad thing is that 1M shares short the stock could have easily sent it to $25+ today had an analyst put out a timely upgrade. Looks like the analysts and their clients want in cheaper at $22 before they start pumping their shares.

 

 

Revenue (ttm):

918.29MRevenue Per Share (ttm):27.421Qtrly Revenue Growth (yoy):257.70%Gross Profit (ttm):176.57MEBITDA (ttm):109.75MNet Income Avl to Common (ttm):13.90MDiluted EPS (ttm):0.36Qtrly Earnings Growth (yoy): N/A Balance SheetTotal Cash (mrq):202.34MTotal Cash Per Share (mrq):5.82Total Debt (mrq):120.04MTotal Debt/Equity (mrq):N/ACurrent Ratio (mrq):2.221Book Value Per Share (mrq):13.633 Cash Flow StatementOperating Cash Flow (ttm):47.17MLevered Free Cash Flow (ttm):34.26M

1 Comments – Post Your Own

#1) On November 06, 2009 at 2:22 PM, IBDvalueinvestin (99.66) wrote:

Samething happened to Generic drug maker BVF yesterday after beating estimates but is modestly higher today. Expect a rebound in PRX shares on Monday.

 

 

Report this comment

Featured Broker Partners


Advertisement